Key Segmentation
By Technology
-
Tandem Mass Spectrometry
-
Immunoassays & Enzymatic Assays
-
Hearing Screening Technology
-
DNA Assays & Next-Generation Sequencing
-
Pulse Oximetry
-
Others
By Test Type
-
Dry Blood Spot Test
-
Hearing Screening Test
-
Critical Congenital Heart Disease Test
By Disorder Type
-
Metabolic Disorders
-
Endocrine Disorders
-
Haemoglobin Disorders
-
Immune Deficiency Disorders
-
Others
By End User
-
Hospitals
-
Maternity & Specialty Clinics
-
Diagnostic Centres
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market player
Frequently Asked Questions
The Newborn Screening Market is expected to grow at a CAGR of 7.68% from 2026 to 2035.
The Newborn Screening Market was valued at USD 1.02 Billion in 2025.
Expanding government-mandated screening panels, technological advances in tandem mass spectrometry and NGS enabling broader multi-disorder detection, and rising parental awareness of preventable genetic disorders are the primary growth factors.
Tandem Mass Spectrometry dominated the Newborn Screening Market with approximately 42.3% share in 2025.
North America dominated the Newborn Screening Market in 2025, with the United States accounting for approximately 82.6% of North American revenues through its comprehensive mandatory RUSP screening programme.